A retrospective study of the incidence of cancer and associated risk factors in kidney transplant patients in a Latin American population between 2007 and 2022
In a Latin American kidney transplant cohort the incidence of post-transplant malignancy was found to be 14% in a median follow-up of 7 years. This study found that risk factors include age, history of cancer prior to transplantation, and diabetes mellitus. Use of mTOR pathway inhibitors was associated with a reduced risk of solid organ neoplasms. No increase in the frequency of PTLD was found in patients receiving costimulation signal inhibitors.
Authors
- Maricely Reina (ORCID: https://orcid.org/0000-0002-1262-1555)
- O Olivares
- Camilo Montero (ORCID: https://orcid.org/0000-0003-2222-3881)
- Carlos Rosselli San Martín (ORCID: https://orcid.org/0000-0002-8485-2010)
- Rodolfo Torres (ORCID: https://orcid.org/0000-0002-4999-3045)
- David Andrade Fonseca (ORCID: https://orcid.org/0000-0002-7233-9041)
- José López Menéndez (ORCID: https://orcid.org/0000-0002-4627-2277)
- Erick Mendoza (ORCID: https://orcid.org/0000-0001-7245-3066)
- Camilo Ruano
Institutions
- Clínica Santa María (CO)
- Fundación Universitaria de Ciencias de la Salud (CO)
- Hospital Universitario Infantil San José (CO)
- Fundación Universitaria Sanitas (CO)
Publication Details
- Journal
- SAGE Open Medicine
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1177/20503121251387972
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00